142 related articles for article (PubMed ID: 32741026)
1. Early estrogen-induced gene 1 facilitates osteoclast formation through the inhibition of interferon regulatory factor 8 expression.
Jeong E; Kim J; Go M; Lee SY
FASEB J; 2020 Sep; 34(9):12894-12906. PubMed ID: 32741026
[TBL] [Abstract][Full Text] [Related]
2. Agrimophol suppresses RANKL-mediated osteoclastogenesis through Blimp1-Bcl6 axis and prevents inflammatory bone loss in mice.
Cao J; Wang S; Wei C; Lin H; Zhang C; Gao Y; Xu Z; Cheng Z; Sun WC; Wang HB
Int Immunopharmacol; 2021 Jan; 90():107137. PubMed ID: 33199235
[TBL] [Abstract][Full Text] [Related]
3. IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1).
Chen Z; Su L; Xu Q; Katz J; Michalek SM; Fan M; Feng X; Zhang P
J Biol Chem; 2015 Dec; 290(50):30163-74. PubMed ID: 26483549
[TBL] [Abstract][Full Text] [Related]
4. Ameloblastin attenuates RANKL-mediated osteoclastogenesis by suppressing activation of nuclear factor of activated T-cell cytoplasmic 1 (NFATc1).
Chaweewannakorn W; Ariyoshi W; Okinaga T; Fujita Y; Maki K; Nishihara T
J Cell Physiol; 2019 Feb; 234(2):1745-1757. PubMed ID: 30105896
[TBL] [Abstract][Full Text] [Related]
5. Blimp1-mediated repression of negative regulators is required for osteoclast differentiation.
Nishikawa K; Nakashima T; Hayashi M; Fukunaga T; Kato S; Kodama T; Takahashi S; Calame K; Takayanagi H
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3117-22. PubMed ID: 20133620
[TBL] [Abstract][Full Text] [Related]
6. Sirt6 cooperates with Blimp1 to positively regulate osteoclast differentiation.
Park SJ; Huh JE; Shin J; Park DR; Ko R; Jin GR; Seo DH; Kim HS; Shin HI; Oh GT; Kim HS; Lee SY
Sci Rep; 2016 May; 6():26186. PubMed ID: 27189179
[TBL] [Abstract][Full Text] [Related]
7. Nodal negatively regulates osteoclast differentiation by inducing STAT1 phosphorylation.
Kim JH; Kim K; Kim I; Seong S; Koh JT; Kim N
J Cell Physiol; 2024 Jun; 239(6):e31268. PubMed ID: 38577903
[TBL] [Abstract][Full Text] [Related]
8. Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis.
Zhao B; Takami M; Yamada A; Wang X; Koga T; Hu X; Tamura T; Ozato K; Choi Y; Ivashkiv LB; Takayanagi H; Kamijo R
Nat Med; 2009 Sep; 15(9):1066-71. PubMed ID: 19718038
[TBL] [Abstract][Full Text] [Related]
9. TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J.
Zhao B; Grimes SN; Li S; Hu X; Ivashkiv LB
J Exp Med; 2012 Feb; 209(2):319-34. PubMed ID: 22249448
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory Effect of Purpurogallin on Osteoclast Differentiation in Vitro through the Downregulation of c-Fos and NFATc1.
Kim K; Kim TH; Ihn HJ; Kim JE; Choi JY; Shin HI; Park EK
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463002
[TBL] [Abstract][Full Text] [Related]
11. Transglutaminase 2 regulates osteoclast differentiation via a Blimp1-dependent pathway.
Kim WS; Kim H; Jeong EM; Kim HJ; Lee ZH; Kim IG; Kim HH
Sci Rep; 2017 Sep; 7(1):10626. PubMed ID: 28878266
[TBL] [Abstract][Full Text] [Related]
12. Tumor Necrosis Factor Alpha Promotes Osteoclast Formation Via PI3K/Akt Pathway-Mediated Blimp1 Expression Upregulation.
Wu L; Guo Q; Yang J; Ni B
J Cell Biochem; 2017 Jun; 118(6):1308-1315. PubMed ID: 27505147
[TBL] [Abstract][Full Text] [Related]
13. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
14. Murine IRF8 Mutation Offers New Insight into Osteoclast and Root Resorption.
Das A; Yesupatham SK; Allison D; Tanwar H; Gnanasekaran J; Kear B; Wang X; Wang S; Zachariadou C; Abbasi Y; Chung MK; Ozato K; Liu C; Foster BL; Thumbigere-Math V
J Dent Res; 2024 Mar; 103(3):318-328. PubMed ID: 38343385
[TBL] [Abstract][Full Text] [Related]
15. Def6 Restrains Osteoclastogenesis and Inflammatory Bone Resorption.
Binder N; Miller C; Yoshida M; Inoue K; Nakano S; Hu X; Ivashkiv LB; Schett G; Pernis A; Goldring SR; Ross FP; Zhao B
J Immunol; 2017 May; 198(9):3436-3447. PubMed ID: 28314855
[TBL] [Abstract][Full Text] [Related]
16. The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors.
Ohyama Y; Ito J; Kitano VJ; Shimada J; Hakeda Y
PLoS One; 2018; 13(1):e0191192. PubMed ID: 29342179
[TBL] [Abstract][Full Text] [Related]
17. Herbacetin inhibits RANKL-mediated osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Li L; Sapkota M; Kim SW; Soh Y
Eur J Pharmacol; 2016 Apr; 777():17-25. PubMed ID: 26923730
[TBL] [Abstract][Full Text] [Related]
18. Cooperation of PU.1 With IRF8 and NFATc1 Defines Chromatin Landscapes During RANKL-Induced Osteoclastogenesis.
Izawa N; Kurotaki D; Nomura S; Fujita T; Omata Y; Yasui T; Hirose J; Matsumoto T; Saito T; Kadono Y; Okada H; Miyamoto T; Tamura T; Aburatani H; Tanaka S
J Bone Miner Res; 2019 Jun; 34(6):1143-1154. PubMed ID: 30721543
[TBL] [Abstract][Full Text] [Related]
19. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
[TBL] [Abstract][Full Text] [Related]
20. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
Lin X; Xiao Y; Chen Z; Ma J; Qiu W; Zhang K; Xu F; Dang K; Qian A
Mol Cell Endocrinol; 2019 Aug; 494():110494. PubMed ID: 31260729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
